Patents by Inventor Noriyoshi Seki

Noriyoshi Seki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds and pharmaceutical use thereof
    Patent number: 11834421
    Abstract: The present invention relates to saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds, or pharmaceutically acceptable salts having ROR? antagonist activity, pharmaceutical compositions comprising the same, and pharmaceutical use thereof. A compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and pharmaceutical use thereof are provided: wherein each substituent is defined as defined in the description.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: December 5, 2023
    Assignee: Japan Tobacco Inc.
    Inventors: Masahiro Yokota, Noriyoshi Seki, Eiichi Watanabe, Shingo Fujioka
  • DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
    Publication number: 20230373932
    Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.
    Type: Application
    Filed: December 20, 2022
    Publication date: November 23, 2023
    Inventors: Masahiro YOKOTA, Taku IKENOGAMI, Eiichi WATANABE, Noriyoshi SEKI, Takayuki SAKAI, Shingo FUJIOKA, Makoto SHIOZAKI, Katsunori SUWA, Yosuke OGOSHI, Masato NOGUCHI, Katsuya MAEDA
  • SATURATED-RING-FUSED DIHYDROPYRIMIDINONE OR DIHYDROTRIAZINONE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
    Publication number: 20220119355
    Abstract: The present invention relates to saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds, or pharmaceutically acceptable salts having ROR? antagonist activity, pharmaceutical compositions comprising the same, and pharmaceutical use thereof. A compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and pharmaceutical use thereof are provided: wherein each substituent is defined as defined in the description.
    Type: Application
    Filed: May 28, 2021
    Publication date: April 21, 2022
    Inventors: Masahiro YOKOTA, Noriyoshi SEKI, Eiichi WATANABE, Shingo FUJIOKA
  • DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
    Publication number: 20210130300
    Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.
    Type: Application
    Filed: June 16, 2020
    Publication date: May 6, 2021
    Inventors: Masahiro YOKOTA, Taku IKENOGAMI, Eiichi WATANABE, Noriyoshi SEKI, Takayuki SAKAI, Shingo FUJIOKA, Makoto SHIOZAKI, Katsunori SUWA, Yosuke OGOSHI, Masato NOGUCHI, Katsuya MAEDA
  • DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
    Publication number: 20190359575
    Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.
    Type: Application
    Filed: December 20, 2018
    Publication date: November 28, 2019
    Inventors: Masahiro YOKOTA, Taku IKENOGAMI, Eiichi WATANABE, Noriyoshi SEKI, Takayuki SAKAI, Shingo FUJIOKA, Makoto SHIOZAKI, Katsunori SUWA, Yosuke OGOSHI, Masato NOGUCHI, Katsuya MAEDA
  • SATURATED-RING-FUSED DIHYDROPYRIMIDINONE OR DIHYDROTRIAZINONE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
    Publication number: 20190300490
    Abstract: The present invention relates to saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds, or pharmaceutically acceptable salts thereof, having ROR? antagonist activity, pharmaceutical compositions comprising the same, and pharmaceutical use thereof. A compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and pharmaceutical use thereof are provided: wherein each substituent is defined as defined in the description.
    Type: Application
    Filed: February 27, 2019
    Publication date: October 3, 2019
    Inventors: Masahiro YOKOTA, Noriyoshi SEKI, Eiichi WATANABE, Shingo FUJIOKA
  • Dihydropyrimidin-2-one compounds and medical use thereof
    Patent number: 10196363
    Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: February 5, 2019
    Assignee: JAPAN TOBACCO INC.
    Inventors: Masahiro Yokota, Taku Ikenogami, Eiichi Watanabe, Noriyoshi Seki, Shingo Fujioka, Makoto Shiozaki, Masato Noguchi
  • AMIDE COMPOUND AND MEDICINAL USE THEREOF
    Publication number: 20160346256
    Abstract: A compound of formula [I-W]: wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 28, 2015
    Publication date: December 1, 2016
    Applicant: Japan Tobacco Inc.
    Inventors: Takaki Maeba, Katsuya Maeda, Masayuki Kotoku, Kazuyuki Hirata, Noriyoshi Seki, Hiroshi Yamanaka, Takayuki Sakai, Shintaro Hirashima, Shingo Obika, Makoto Shiozaki, Masahiro Yokota
  • DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
    Publication number: 20160194290
    Abstract: A compound of Formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is defined as in the specification.
    Type: Application
    Filed: December 11, 2015
    Publication date: July 7, 2016
    Inventors: Masahiro YOKOTA, Taku IKENOGAMI, Eiichi WATANABE, Noriyoshi SEKI, Takayuki SAKAI, Shingo FUJIOKA, Makoto SHIOZAKI, Katsunori SUWA, Yosuke OGOSHI, Masato NOGUCHI, Katsuya MAEDA
  • TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF
    Publication number: 20160137639
    Abstract: A compound represented by Formula [I]: or pharmaceutically acceptable salt thereof, wherein each symbol is as defined in the description.
    Type: Application
    Filed: October 25, 2013
    Publication date: May 19, 2016
    Inventors: Masayuki KOTOKU, Takaki MAEBA, Noriyoshi SEKI, Shintaro HIRASHIMA, Shingo FUJIOKA, Shingo OBIKA, Hiroshi YAMANAKA, Masahiro YOKOTA, Takayuki SAKAI, Kazuyuki HIRATA, Katsuya MAEDA, Makoto SHIOZAKI, Yuko SHINAGAWA, Taku IKENOGAMI, Satoki DOI, Takahiro OKA, Takuya MATSUO, Yoshihiro SUWA, Keisuke ITO, Satoru NOJI, Yoshinori HARA
  • AMIDE COMPOUND AND MEDICINAL USE THEREOF
    Publication number: 20140296306
    Abstract: A compound of formula [I-W]: wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 30, 2013
    Publication date: October 2, 2014
    Applicant: Japan Tobacco Inc.
    Inventors: Takaki Maeba, Katsuya Maeda, Masayuki Kotoku, Kazuyuki Hirata, Noriyoshi Seki, Hiroshi Yamanaka, Takayuki Sakai, Shintaro Hirashima, Shingo Obika, Makoto Shiozaki, Masahiro Yokota
  • Amide compound and medicinal use thereof
    Patent number: 8604069
    Abstract: A compound of formula [I-W]: wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: December 10, 2013
    Assignee: Japan Tobacco Inc.
    Inventors: Takaki Maeba, Katsuya Maeda, Masayuki Kotoku, Kazayuki Hirata, Noriyoshi Seki, Hiroshi Yamanaka, Takayuki Sakai, Shintaro Hirashima, Shingo Obika, Makoto Shiozaki, Masahiro Yokota
  • AMIDE COMPOUND AND MEDICINAL USE THEREOF
    Publication number: 20120322837
    Abstract: A compound of formula [I-W]: wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 27, 2012
    Publication date: December 20, 2012
    Applicant: JAPAN TOBACCO INC.
    Inventors: Takaki Maeba, Katsuya Maeda, Masayuki Kotoku, Kazuyuki Hirata, Noriyoshi Seki, Hiroshi Yamanaka, Takayuki Sakai, Shintaro Hirashima, Shingo Obika, Makoto Shiozaki, Masahiro Yokota